Eleusian Biosciences CEO, Jonathan Gilbert, will speak at the Peak Asset Management's Webinar on Thursday June 18th at 7:30PST. GreenStar recently announced non-binding LOI with Eleusian Vancouver, ...
- Brings seasoned pharmaceutical leader and executive to GreenStar: Maghsoud Dariani, Eleusian's Chief Science Officer to join GreenStar's executive team as Chief Science Officer - Eleusian expands ...
Additional provisional patent application, strengthens IP portfolio of therapeutics for the treatment of mild traumatic brain injuries (mTBI) with PTSD or PTSD alone. "The goal at Eleusian has been to ...
With the acquisition of Eleusian and appointments of Mr. Gilbert and Mr. Dariani, GreenStar believes it represents a new standard for excellence within the psychedelic medicine industry. GreenStar ...
Additional provisional patent application, strengthens IP portfolio of therapeutics for the treatment of mild traumatic brain injuries (mTBI) with PTSD or PTSD alone. In 2017, the United States Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results